🇹🇷 Türkçe

Debate: Epigenetic Changes in Psychiatric Disorders — Causation vs. Correlation?

The Question

Do epigenetic modifications (histone marks, DNA methylation changes) observed in psychiatric disorders cause those disorders, or are they merely correlates — downstream consequences of the disorder, its treatments, or confounding factors?

Position A: Epigenetic Changes Are Causal Contributors

Argument:

  • Animal models demonstrate that experimentally inducing specific epigenetic changes produces disorder-relevant behaviors. Example: targeted overexpression of H3K9me2 at the FosB locus in mouse NAc (via engineered zinc finger protein) increased depression-like behavior.
  • Manipulation of chromatin enzymes (HDAC inhibition, DNMT overexpression/inhibition) bidirectionally modulates stress susceptibility and antidepressant response in predictable directions.
  • Early life adversity → epigenetic changes at Nr3c1, BDNF → lasting stress dysregulation: this causal chain is supported across rodent and human data.
  • Genetic variants in chromatin regulator genes (e.g., H3K4 methyltransferase regulators) directly increase risk for bipolar disorder and SCZ — implicating the epigenetic machinery itself.

Key evidence:

  • Zinc finger-targeted H3K9me2 at FosB → reduced ΔFosB expression → increased depression-like behavior (Heller et al. 2014)
  • Dnmt3a overexpression in NAc → increased depression-like behavior
  • HDAC inhibition → antidepressant effect (multiple paradigms)

Position B: Epigenetic Changes Are Correlates or Consequences

Argument:

  • Most human epigenetic data comes from postmortem brain tissue — it is impossible to establish temporal order from a snapshot.
  • Psychiatric disorders involve chronic medications, substance use, sleep disruption, and metabolic changes — all of which affect the epigenome independently of the disorder itself.
  • Many epigenetic findings are not replicated across labs or cohorts. Postmortem studies are confounded by cell-type heterogeneity, postmortem interval, and cause of death.
  • Animal models of psychiatric disorders have limited construct validity — stress-induced behavioral changes are not the same as clinical depression or schizophrenia.
  • A correlation between epigenetic state and gene expression does not establish that the epigenetic state is driving behavior.

Key concerns:

  • Antipsychotic exposure independently alters DNA methylation in rodents (olanzapine in rat hippocampus)
  • Few findings from animal models have been validated in human postmortem tissue and vice versa
  • No single epigenetic modification is deterministic for a change in gene activity

Current State of the Field

  • Causality is established for specific epigenetic manipulations in specific animal paradigms.
  • Causality in humans remains unproven for most claims.
  • Locus-specific epigenetic editing tools (zinc finger proteins, TALEs, CRISPR-based epigenome editors) are being developed to test causal claims more rigorously — early results support causality at some loci.
  • The field recognizes this as a high-priority unresolved question.

Bottom line: Epigenetic changes likely include both causal contributors and correlates. Distinguishing these requires locus-specific, temporally ordered, and ideally reversible interventions — increasingly feasible with new tools but not yet systematically applied.